NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Brown University
Brown University
Therakos LLC
City of Hope Medical Center
Hadassah Medical Organization
Mayo Clinic
Indiana University
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Biogen
Massachusetts General Hospital
Massachusetts General Hospital
Thomas Jefferson University
Thomas Jefferson University
ImmunityBio, Inc.
ImmunityBio, Inc.
Mayo Clinic
University of Kansas Medical Center
European Institute of Oncology
University of Alabama at Birmingham
Immunocore Ltd
Medical University of Graz
TJ Biopharma Co., Ltd.
Johns Hopkins University
University of Miami
Vastra Gotaland Region
Dana-Farber Cancer Institute
Multidisciplinary Association for Psychedelic Studies
University of Louisville
Rain Oncology Inc
Northwestern University
Nova Scotia Cancer Centre
Fondazione Melanoma Onlus
Alliance for Clinical Trials in Oncology
Targovax ASA
Providence Health & Services
Dana-Farber Cancer Institute
Rakuten Medical, Inc.
Bristol-Myers Squibb
Excel Diagnostics and Nuclear Oncology Center
Pierre Fabre Medicament
Institut du Cancer de Montpellier - Val d'Aurelle
Innovent Biologics (Suzhou) Co. Ltd.
Rush University Medical Center
Melanoma Institute Australia
Presage Biosciences
National Institutes of Health Clinical Center (CC)
Northwestern University
Northwestern University
Yale University
4SC AG